Ariemedi

About Ariemedi

Based in Beijing, Ariemedi operates at the intersection of medical technology and artificial intelligence, specializing in surgical navigation systems. Founded in 2016, the company develops and manufactures intelligent medical devices that leverage augmented reality to enhance surgical precision. The firm primarily serves the surgical robotics and medical imaging equipment markets, providing integrated solutions for intelligent surgeries.

Ariemedi's core offering is an endoscopic surgery navigation system that utilizes augmented reality. This system processes patient data, such as CT scans, before an operation to create a 3D reconstruction of the patient's anatomy. During surgery, the technology tracks the endoscope's position in real-time and overlays the 3D model onto the live endoscopic feed. This fusion of pre-operative images and the real-time view provides surgeons with a detailed guide to complex anatomical structures, aiming to improve the safety and accuracy of procedures. The company has also developed its own optical and electromagnetic tracking and positioning devices.

A significant milestone for Ariemedi was achieved in October 2021, when its primary product, an endoscopic skull base surgery navigation device, received registration certificate approval from China's National Medical Products Administration (NMPA). The company has secured substantial funding to support its growth, including a Series A+ round in late 2022, with the capital intended for research collaborations, clinical trials, product enhancements, and market expansion.